Cardiac Diagnostics Articles & Analysis
13 news found
CardioWise, Inc. has recently completed development of the first fully integrated version of its Multiparametric Strain Analysis Software (MPSA™), which is uniquely capable of analyzing the three-dimensional motion of the heart that is acquired from cardiac MRI images and then comparing the analysis at 15,300 points to the motion of a normal heart model. ...
These products will be targeted at improving diagnostic capabilities for complex cardiac arrhythmias. Allen Kamer, a founding partner of Qure Ventures, and Dr. ...
” CardioWise’s SQuEEZ® is based on the ability in sequential high-resolution cardiac CT scans to track movement of individual points on the endocardium during the contraction of the heart. The analysis of SQuEEZ parameters has the potential to improve the ability to quantify accurately the ability of the heart to pump blood through the left ventricle. ...
Partnering with Stratus and benefiting from its infrastructure and platform eliminates that hurdle and paves the way toward addressing the unmet need for endpoints, safety tools and computational diagnostics." Beacon's platform provides an architectural foundation for discovery of robust quantitative neurobiomarkers that subsequently can be deployed for patient stratification or ...
” About Positron Corporation About Positron: Positron Corporation is a nuclear medicine PET imaging company specializing in the field of cardiac Positron Emission Tomography imaging - the gold standard in cardiac diagnostics. ...
Dwyer will oversee the continued development of Coala’s patient-centric solutions that use smart algorithms to digitally transform the field of cardiac diagnostics and help win the battle against the world’s leading cause of death—heart disease. ...
With the patient friendly Coala, we can now follow our patients and review diagnostic quality cardiac data as long as it’s medically ...
SEATTLE, May 26, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today it received CE mark certification for the 14-Day version of the Carnation Ambulatory Monitor (“CAM”) patch, the industry’s only P-wave centric ...
Seattle, WA — March 25, 2020 — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that its Carnation Ambulatory Monitor (“CAM™”) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have ...
“We are proud to have been chosen as a Top Ten Finalist in the Cardiovascular Digital Diagnostic category of the 2019 UCSF Digital Health Awards,” said Jack Coats, CEO of CardioWise. ...
The US Patent application was filed November 11, 2016. The software uses cardiac CT patient data sets to determine which heart failure patients may benefit from implantation of a Cardiac Resynchronization Therapy device and can guide the placement of leads to ensure that the device is effective. ...
The CardioWise analysis software is uniquely capable of analyzing the threedimensional motion of the heart that is acquired from cardiac MRI images and then comparing the analysis at 15,300 points to the motion of a normal heart model. ...
Under the direction of Geoffrey Dalbow, Principle Investigator and Chief Technology Officer of CardioWise, the team will further refine Multiparametric Strain (MPS™), its patent-pending, non-invasive Cardiac Magnetic Resonance Imaging analysis software. “Geoffrey’s extensive experience in this area and his connections to industry leaders have supported our ...